Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABUSED WOMENS AID IN CRISIS INC

UEI: JKDLUZ2TQWM3CAGE: 4ETQ2

ABUSED WOMENS AID IN CRISIS INC is a federal contractor, registered under UEI JKDLUZ2TQWM3 and CAGE code 4ETQ2. It has been awarded $11,327,015 across 48 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Justice (doj), Department Of Housing And Urban Development, and Department Of Justice.

Contact Information

Registration and classification details

Registration

UEI Code

JKDLUZ2TQWM3

CAGE Code

4ETQ2

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

6DA8

NAICS Codes

624221Temporary Shelters(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABUSED WOMENS AID IN CRISIS INC operates as a nonprofit service provider focused on crisis intervention and support for survivors of domestic violence and gender-based abuse. Leveraging its primary NAICS code 624221, which classifies it under “Other Social Assistance Activities,” the organization de...

ABUSED WOMENS AID IN CRISIS INC operates as a nonprofit service provider focused on crisis intervention and support for survivors of domestic violence and gender-based abuse. Leveraging its primary NAICS code 624221, which classifies it under “Other Social Assistance Activities,” the organization delivers direct human services including emergency shelter, safety planning, counseling, advocacy, and community outreach. Its core capabilities center on trauma-informed care, case management, and coordination with law enforcement and social service networks to ensure holistic support for vulnerable populations. The organization specializes in culturally responsive interventions tailored to underserved communities in Alaska, with an emphasis on geographic accessibility in remote and rural regions. While no certifications are held, its operational model is grounded in best practices for victim-centered services, including confidentiality protocols, multidisciplinary team coordination, and crisis response protocols aligned with state and federal guidelines for domestic violence assistance. No award history is available to infer specific agency partnerships or contract-based performance. Consequently, there is no demonstrable track record of federal contracting activity or formal relationships with government departments. The organization’s industry focus is exclusively within social assistance services, specifically addressing intimate partner violence and crisis stabilization. It does not engage in IT, infrastructure, or procurement-based government contracting, positioning itself as a community-based service provider rather than a federal vendor. ABUSED WOMENS AID IN CRISIS INC is structured as a nonprofit entity with an 8H designation, indicating it is a Native American-owned concern. It operates primarily from Anchorage, Alaska, serving the broader Alaska region. Its government market positioning is non-contractual; it functions as a direct service provider funded through grants, donations, and state allocations rather than federal contracts.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Justice (doj)$6.9M60.9%
Department Of Housing And Urban Development$1.8M16%
Department Of Justice$1.8M15.6%
Department Of Health And Human Services (hhs)$704.7K6.2%
Department Of Agriculture (usda)$87.7K0.8%
Other agencies (1 agencies, <0.5% each)$55.6K0.5%
Awards by NAICS
Export
- Unknown NAICS$11.3M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABUSED WOMENS AID IN CRISIS INC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 493190
Federal
Vehicle Recompete: Idc 15M50022DA4400003This contract is a total small business set-aside with a ceiling value of nearly $3 million, awarded by the U.S. Marshals Service under the Department of Justice. It covers towing, storage, maintenance, and disposal services for seized and/or forfeited vehicles across several districts in the Northeast, specifically Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. The ordering period for this contract extends until late September 2027, although currently, there are no active task orders valued at zero dollars. Key task orders previously issued to RBEX, Inc. indicate substantial past expenditures, with two major task orders valued at over $680,000 and $524,000 respectively. The contract is identified as a recompete, signaling a continuation or replacement of existing services with moderate confidence in the likelihood of award. It is associated with NAICS code 493190, which relates to warehousing and storage services. The solicitation was last posted in March 2026, and it remains a pre-forecast status, suggesting planning stages for future service requirements. The contract specifically supports the logistical and operational needs of vehicle management related to law enforcement activities in the specified districts, emphasizing the critical role of small businesses in fulfilling federal government service contracts in the justice sector.
USMS U.S. Department Of Justice

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541715
Federal
Vehicle Recompete: Idc 75N95022D00017This contract is an indefinite delivery contract vehicle (IDC) with the identifier 75N95022D00017, overseeing the ordering period from September 5, 2022, through September 4, 2027. It supports the National Institute on Drug Abuse (NIDA) data, statistics, and clinical trial operations under the Department of Health and Human Services, managed by the National Institutes of Health (NIH). The contract has a ceiling value of approximately $44.3 million and does not involve any set-aside provisions. It represents a full recompete classification, indicating a competitive solicitation process to award the contract. Currently, there are no active task orders valued at zero, but several significant task orders have been executed under this vehicle. Several key task orders highlight the contract’s scope and value, all awarded to The Emmes Company, LLC. These task orders cover a variety of research and analytical services, including the management and support of the Data and Statistics Center (DSC) from March 2025 to February 2026 ($1.85 million), data analysis related to GLP-1 as an adjunct to buprenorphine from May 2025 to February 2028 ($1.4 million), and various other clinical and secondary analysis projects concerning opioid use disorder and related research, with task order values ranging from approximately $375,000 to $800,000. The work performed under these task orders reflects a comprehensive support framework for clinical trials and data management activities essential to advancing research efforts around drug abuse and treatment strategies.
National Institutes Of Health Nida

POSTED

6 months ago

DEADLINE

N/A
View Details